Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 3/2020

Ausgabe 3/2020

Inhaltsverzeichnis ( 26 Artikel )

01.09.2020 | editorial | Ausgabe 3/2020

Creating the “new normal” post-Coronavirus world—web-communication replacing face-to-face interaction

Wolfgang Hilbe MD, Andreas Pircher MD, PhD, Thorsten Füreder MD, Holger Rumpold MD, Eberhard Gunsilius MD, Rupert Bartsch MD

01.09.2020 | editorial | Ausgabe 3/2020

News from ASH 2019

Eberhard Gunsilius

01.09.2020 | editorial | Ausgabe 3/2020

Treatment of advanced melanoma

Prof. Dr. med. univ. Van Anh Nguyen

01.09.2020 | editorial | Ausgabe 3/2020

Rectal cancer: latest developments and innovative new treatment concepts

Arno Amann MD

01.09.2020 | editorial | Ausgabe 3/2020

Therapies in flux: highlights of the 2019 San Antonio Breast Cancer Symposium (SABCS)

Simon Peter Gampenrieder

01.09.2020 | editorial | Ausgabe 3/2020

Managing an oncology clinic during the COVID-19 pandemic—how we did it in Sarajevo?

Prof. Semir Beslija MD, PhD

31.08.2020 | editorial | Ausgabe 3/2020

memo—publisher’s report 2019

Dr. Alois Sillaber

19.05.2020 | short review | Ausgabe 3/2020 Open Access

Fine-tuning front-line therapy in chronic lymphocytic leukemia

News from ASH 2019
Jan-Paul Bohn MD, PhD, Prof. Dominik Wolf MD

20.05.2020 | short review | Ausgabe 3/2020 Open Access

ASH highlights 2019: “aggressive B-cell lymphoma”

Univ.-Prof. Dr. med. Clemens A. Schmitt

13.05.2020 | short review | Ausgabe 3/2020

Highlights of ASH 2019—multiple myeloma

Prof. Dr. Heinz Ludwig

26.05.2020 | short review | Ausgabe 3/2020

Myeloid diseases—Chronic Myeloid Leukemia (CML)—report from ASH 2019 on new developments

Prim. Univ.-Prof. Dr. Andreas L. Petzer

20.05.2020 | short review | Ausgabe 3/2020 Open Access

New systemic treatment options in mycosis fungoides and Sézary syndrome

Magdalena Seidl-Philipp MD, Van Anh Nguyen MD

03.07.2020 | review | Ausgabe 3/2020 Open Access

Patient-reported outcomes and psycho-oncological screening in hematology: a practical example of routine electronic monitoring

Jens Lehmann MSc, Lisa M. Wintner, Monika Sztankay, Wolfgang Willenbacher, Roman Weger, Walpurga Weyrer, Gerhard Rumpold, Bernhard Holzner

25.05.2020 | original report | Ausgabe 3/2020

Comparison of outcomes of two non-BCNU-containing conditioning regimens used in autologous stem cell transplantation for relapsed/refractory lymphoma

Amro Mohamed Sedky El-Ghammaz, Maha El-Zimaity, Afaf Abdel-Aziz Abdel-Ghaffar

15.04.2020 | short review | Ausgabe 3/2020 Open Access

Adjuvant and neoadjuvant treatment of melanoma

Peter Koelblinger M.D.

15.04.2020 | short review | Ausgabe 3/2020 Open Access

The therapeutic landscape of advanced melanoma

Erika Richtig

14.08.2020 | short review | Ausgabe 3/2020 Open Access

The future of combination therapies in advanced melanoma

Christoph Hoeller

26.05.2020 | original report | Ausgabe 3/2020

Rectal cancer among younger Egyptian patients—clinico-pathological features and oncologic outcomes: A single institution experience

Amir M. Zaid, Engy M. Aboelnaga MD, Amal Halim, Mohamed Abdelkhalek, Saleh S. Elbalka, Mohamed Zuhdy, Ahmed M. Fareed, Eman M. Ibrahim, Hosam Halim, Islam H. Metwally

13.03.2020 | short review | Ausgabe 3/2020

Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer

Which way to go?
Fabian Lunger MD, PhD, Georgios Peros MD

15.04.2020 | short review | Ausgabe 3/2020 Open Access

Neoadjuvant chemoradiotherapy in rectal cancer

Are there new drug combinations on the horizon?
Christoph Reinhold Arnold MD, PhD, Julian Mangesius MD, Robert Jäger MD, Ute Ganswindt MD

16.04.2020 | short review | Ausgabe 3/2020

Circulating tumour DNA-guided adjuvant chemotherapy in colorectal carcinoma

Andreas Reichinger MD, Holger Rumpold

30.06.2020 | case report | Ausgabe 3/2020

Four lines of immunochemotherapy combinations in a young patient with an aggressive metastatic colorectal cancer

Frédéric H. Witte, Wolfgang Hilbe, Ercan Müldür

13.07.2020 | short review | Ausgabe 3/2020

San Antonio Breast Cancer Symposium 2019: human epidermal growth factor receptor 2(HER2)-positive breast cancer and image-guided biopsy to detect pathologic complete response (pCR)

Clemens Dormann M.D.

07.05.2020 | short review | Ausgabe 3/2020 Open Access

Treatment options in early triple-negative breast cancer

Update from the San Antonio Breast Cancer Symposium 2019
Christoph Suppan, Marija Balic

01.09.2020 | short review | Ausgabe 3/2020 Open Access

San Antonio 2019: interesting topics for daily clinical practice in breast cancer

Arik Galid MD

25.05.2020 | original report | Ausgabe 3/2020

Biologically effective dose and overall survival in stereotactic body radiotherapy for lung tumors

Osamu Tanaka M.D, Norihiko Funaguchi M.D., Sayaka Toyoshi M.D., Takuya Taniguchi M.P., Kousei Ono M.P., Chiyoko Makita M.D., Masayuki Matsuo M.D.

Aktuelle Ausgaben